Indiana Governor Orders State Agencies to Meet Cannabis Advocates

Indiana's Republican Governor has directed multiple state agencies to hold meetings with medical marijuana advocates, marking a notable shift in one of the nation's most restrictive cannabis policy states. The directive comes just one day after the Trump administration confirmed federal cannabis rescheduling is proceeding.

Officials from the Indiana Department of Veterans Affairs, Department of Health, and other state agencies met with Hoosier Veterans and medical cannabis advocacy groups this week. The timing suggests state leadership is beginning to acknowledge the potential policy implications of federal Schedule III reclassification.

Indiana currently maintains some of the strictest cannabis laws in the country. The state has no medical marijuana program, no decriminalization measures, and possession of any amount remains a criminal offense. But the governor's directive to engage with advocates represents the first meaningful state-level dialogue on cannabis policy in years.

The Federal Context

The meetings follow the Department of Justice's announcement that cannabis will move from Schedule I to Schedule III under the Controlled Substances Act. While rescheduling doesn't legalize marijuana at the federal level, it does create regulatory pressure on states with no medical access programs.

Schedule III classification would place cannabis alongside medications like ketamine and anabolic steroids—substances recognized as having accepted medical use. For states like Indiana that treat marijuana as having no medical value, the federal shift creates a policy contradiction that's becoming harder to ignore.

Veterans groups have been particularly vocal in Indiana, citing the state's veteran population of over 400,000. Many veterans have relocated to neighboring Michigan or Illinois to access medical cannabis for PTSD, chronic pain, and other service-related conditions.

What State Agencies Are Considering

While details of the meetings remain limited, sources familiar with the discussions say agencies are exploring what a medical marijuana program might look like if Indiana were to establish one. Questions on the table include licensing structures, qualifying medical conditions, and how a state program would interact with federal rescheduling.

The Indiana Department of Health has historically opposed medical marijuana legislation, citing concerns about public health impacts and federal illegality. But with federal rescheduling eliminating the latter argument, the department's position may be evolving.

Indiana lawmakers have introduced medical marijuana bills in recent sessions, but none have advanced far in the Republican-controlled legislature. The governor's willingness to direct agencies to meet with advocates could signal a shift in the administration's stance—or at minimum, acknowledgment that federal policy changes require state-level response.

The Political Landscape

Indiana remains one of just 12 states with no medical marijuana program. Neighboring states Michigan, Illinois, and Ohio all have established medical and adult-use markets, creating a patchwork that Indiana residents navigate by crossing state lines.

Polling in Indiana has consistently shown majority support for medical marijuana, with recent surveys indicating 70% or higher approval. Yet the state's conservative legislature has resisted reform efforts, often citing federal prohibition as justification.

That justification weakens considerably with Schedule III reclassification. While marijuana would remain federally controlled, its recognition as having medical value undercuts the primary argument Indiana officials have used to oppose state programs.

What Happens Next

The meetings between state agencies and advocates are ongoing, with additional sessions scheduled in coming weeks. Advocacy groups are pushing for the governor to support medical marijuana legislation in the next legislative session, which begins in January 2026.

Whether these discussions translate into actual policy proposals remains uncertain. The governor has not publicly stated support for medical marijuana, and his directive to agencies could be exploratory rather than indicative of imminent reform.

But the fact that meetings are happening at all represents movement in a state that has long been one of the nation's most resistant to cannabis policy change. Federal rescheduling is creating pressure that even conservative state administrations are beginning to acknowledge.

---

This article is based on original reporting by www.marijuanamoment.net.